Compare REI & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REI | MOBI |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.1M | 399.7M |
| IPO Year | 2013 | 2026 |
| Metric | REI | MOBI |
|---|---|---|
| Price | $1.14 | $11.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 92.6K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,178,072.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.17 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $10.55 |
| 52 Week High | $2.00 | $15.19 |
| Indicator | REI | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 35.70 |
| Support Level | $0.84 | $10.67 |
| Resistance Level | $1.42 | $12.68 |
| Average True Range (ATR) | 0.06 | 0.88 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 16.00 | 8.39 |
Ring Energy Inc is an independent oil and natural gas exploration and production company based in the United States. It is engaged in oil and natural gas development, production, acquisition, and exploration activities, currently focused on the Permian Basin of Texas. The company's drilling operations target the oil and liquids-rich producing formations in the Northwest Shelf and the Central Basin Platform, in the Permian Basin in Texas.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.